ASPR issues supplemental information on REGEN-COV packaging, labeling and storage
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response today issued on several key changes related to the REGEN-COV COVID-19 monoclonal antibody therapy. According to ASPR, hospitals receiving this week’s shipment of REGEN-COV should note that it will arrive in one of two packaging configurations: REGEN-COV Dose Packs (2 Vial) or Casirivimab and Imdevimab Co Pack (2 vials per carton). ASPR says REGEN-COV in both packaging configurations may be used to prepare and administer intravenous infusions as well as subcutaneous injections. Additional dosing and administration information can be found .
Related News Articles
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England…
Headline
A study published April 8 by the Public Library of Science’s Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of…